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Editorial on the Research Topic
Endocrine Modulators of Neurological Processes: Potential Treatment Targets of Pediatric
Neurological Diseases
INTRODUCTION
Over the last decade, significant progress has been made in understanding the effects of
neuroendocrine regulators, represented by brain gut peptides, leptin, melatonin, as well as
ketogenic diet (KD), on brain development, brain injury repair and early warning. This Research
Topic contains 10 articles, contributed by 40 authors, from 17 countries (plus 28 experts
participating in the review and editing), focusing on most recent understanding of the effects of
neuroendocrine regulators on pediatric neurological diseases, including the predictive value of
ghrelin, leptin, and other adipokines in the early diagnosis and intervention on pediatric
neuropathy, the progress of basic research and the potential translational medicine value, etc.
Gastrointestinal peptides play important roles by regulating feeding and energy homeostasis.
Ghrelin is a multifaceted gut hormone that is famously known as a “hunger hormone,” just the
opposite of cholecystokinin (CCK), which is referred to as a “satiety factor.” Both hormones act via
the peripheral vagal afferent and interact to modulate feeding regulation (1). The anticonvulsant
effects of ghrelin and CCK have been reported (2, 3). Notably, ghrelin is expected to be an effective
therapy for lean patients with cachexia caused by chronic heart failure, anorexia nervosa, andn.org February 2021 | Volume 12 | Article 6552901
Ni et al. Treatment Targets of Neuropediatric Diseasesfunctional dyspepsia (4). In this Research Topic, Marchiò et al.
evaluated ghrelin and growth during 1 year of ketogenic diet (KD).
They examined a small cohort of six children (two males and four
females, age range 3–10.4 years) affected by refractory epilepsy,
who received the KD as add-on treatment. The results showed
that ghrelin plasma levels are consistently reduced in children
with refractory epilepsy andmaintained on the KD. This change
was associated with low growth indexes in the majority
of patients.
Although the mechanism of KD’s anti-epileptogenic and
neuroprotective effects has been studied in recent years (5, 6),
there is still a lack of spectral molecular expression research. Here
a proteomics study by Zheng et al. analyzed the effects of KD
against lithium chloride/pilocarpine-induced status epilepticus
(SE) in rats. Seventy-nine proteins in hippocampus showing a
significant change in abundance between SE and control (Ctr)
groups were reciprocally regulated in the SE + KD group
compared to the SE group (i.e., the seizure-induced change was
reversed by KD). Of these, five (dystrobrevin, centromere protein
V, oxysterol-binding protein, tetraspanin-2, and progesterone
receptor membrane component 2) were verified by parallel
reaction monitoring. Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway analysis indicated that proteins of
the synaptic vesicle cycle pathway were enriched both among
proteins differing in abundance between SE and Ctr groups as
well as between SE + KD and SE groups.
Chen et al. investigated the effects of different zinc
concentrations in the diet on long-term neurobehavioral and
seizure thresholds following lithium chloride/pilocarpine-
induced developmental seizures. They found that zinc
supplementation for 4 weeks significantly improved injury-
related changes, and rescued abnormalities in GPR39, ZnT-3,
and MBP expression in the hippocampus, which suggests that
the role of zinc ions in developmental convulsive brain injury
may not be purely excitotoxic as previously thought (7–9), but
may play a protective role in the brain as mentioned earlier (10).
In a perspective article by Doenyas, a more comprehensive
approach termed the “gut-immune-endocrine-brain” axis, is
taken, based on which a personalized treatment plan for
autism spectrum disorder (ASD) is presented.
Another clinical Cross-Sectional Study by Chen et al. in the
present Research Topic investigated the association among
plasma adipokines, mainly leptin, visfatin, adiponectin, or IL-6,
and the prognosis of febrile seizures (FS). The main findings were
that serum adiponectin and IL-6 levels were significantly higher
in the FS group than in the FC and HC groups, while there was
no statistical difference between the FC and HC groups,
indicating that higher plasma levels of IL-6 and adiponectin
could serve as an additional biomarker in the early treatment or
follow-up of FS children.
Melatonin is an indoleamine secreted by the pineal gland. It
can be used for the treatment of children with developmental
disorders, such as ASD and attention deficit/hyperactivity
disorder to improve their sleep disturbance (11, 12). Animal
experiments and limited human data have confirmed the
neuroprotective effect of melatonin on hypoxic-ischemic (HI)Frontiers in Endocrinology | www.frontiersin.org 2or developmental seizure-induced excitotoxic brain damage (13–
15). Here, two studies have explored the molecular signaling
mechanism of the neuroprotective effect of melatonin through
the in vitro glutamate excitotoxic injury model and the in vivo
cerebral palsy model. Wang et al. investigated the impact of
melatonin on the parameters of glutamate cytotoxicity in mouse
HT22 hippocampal neurons and tested the hypothesis that
melatonin confers neuroprotective effects via mitochondrial
oxidative stress/autophagy signaling. The findings indicate that
melatonin exerts neuroprotective effects against glutamate-
induced excitotoxicity by reducing mitophagy-related oxidative
stress and maintaining mitochondrial function. Sun et al. used
plppr5 knockout (plppr5-/-) mice and their wild-type littermates
to establish a model of HI injury to further explore the effects
of melatonin on brain injury and the role of plppr5 in this
treatment in an HI model, which mainly focuses on cognition,
exercise, learning and memory. They found that plppr5
knockout aggravated HI damage and partially weakened the
neuroprotective effect of melatonin in some aspects (such as
novel object recognition tests and partial nerve reflexes).
Interactions between the brain and distinct adipose depots have
a key role in maintaining energy balance, thereby promoting brain
development, among them, leptin play a key role (16). Recently,
there has been renewed interest in the role of leptin in repairing
developmental brain damage (17, 18). Here, a review article by
Fujita andYamashita summarizenovel functionsof leptin inanimal
models ofneurodegenerativediseases. Specifically, they focuson the
emerging evidence for the role of leptin in non-neuronal cells in the
central nervous system, including astrocytes, microglia, and
oligodendrocytes, which provides helpful information to establish
therapeutic strategies to address the neurological diseases.
In addition, the study by Zhao et al. explored the significance of
the a2 isoform of Na+/K+-ATPase in the regulation of the
electrophysiological properties of skeletal muscle cells by b-
Catenin. The review article by Wu et al. discussed the emerging
roles of long non-coding RNAs in chronic neuropathic pain.
In conclusion, the present clinical and basic studies allow us a
better understanding of the effects of endocrine modulators on
pediatric neurological diseases. We hope that the information
gathered from this Research Topic will help promote clinical
translational medical research to better prevent and treat these
injuries in the near future.AUTHOR CONTRIBUTIONS
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